These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4128366)

  • 21. [Clinical aspects and therapy of infections with herpes simplex viruses].
    Schneweis KE; Eis-Hübinger AM
    Internist (Berl); 1992 Sep; 33(9):581-5. PubMed ID: 1328106
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of oral treatment with acyclovir and bromovinyldeoxyuridine on the establishment of maintenance of latent herpes simplex virus infection in mice.
    Field HJ; De Clercq E
    J Gen Virol; 1981 Oct; 56(Pt 2):259-65. PubMed ID: 6273499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone marrow-derived cells expand memory CD8+ T cells in response to viral infections of the lung and skin.
    Belz GT; Wilson NS; Smith CM; Mount AM; Carbone FR; Heath WR
    Eur J Immunol; 2006 Feb; 36(2):327-35. PubMed ID: 16402408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new promising candidate to overcome drug resistant herpes simplex virus infections.
    Zinser E; Krawczyk A; Mühl-Zürbes P; Aufderhorst U; Draßner C; Stich L; Zaja M; Strobl S; Steinkasserer A; Heilingloh CS
    Antiviral Res; 2018 Jan; 149():202-210. PubMed ID: 29155164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The antiviral activity of peptide immunomodulator "Gepon" in experimental infections caused by herpes simplex viruses types 1 and 2].
    Barinskiĭ IF; Alimbarova LM; Lazarenko AA; Ataullakhanov RI
    Vopr Virusol; 2003; 48(5):30-3. PubMed ID: 14598478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antivirals for herpes simplex viruses.
    Sawleshwarkar S; Dwyer DE
    BMJ; 2015 Jul; 351():h3350. PubMed ID: 26160487
    [No Abstract]   [Full Text] [Related]  

  • 27. Editorial overview: Antiviral strategies.
    De Clercq E; Schinazi RF
    Curr Opin Virol; 2016 Jun; 18():v-vi. PubMed ID: 27521687
    [No Abstract]   [Full Text] [Related]  

  • 28. Aromatic sulfonic acids as viral inhibitors. Structure-activity study using rhino, adeno 3, herpes simplex, and influenza viruses.
    Akerfeldt S; Westin G; Jansson T
    J Med Chem; 1971 Jul; 14(17):595-600. PubMed ID: 4365198
    [No Abstract]   [Full Text] [Related]  

  • 29. Neutralization of an infectious herpes simplex virus-antibody complex by anti-gamma-globulin.
    Ashe WK; Notkins AL
    Proc Natl Acad Sci U S A; 1966 Aug; 56(2):447-51. PubMed ID: 4165517
    [No Abstract]   [Full Text] [Related]  

  • 30. Mechanism of acquired resistance to herpes simplex virus infection as studied in nude mice.
    Nagafuchi S; Oda H; Mori R; Taniguchi T
    J Gen Virol; 1979 Sep; 44(3):715-23. PubMed ID: 231089
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of oral treatment with 6-O-butanoyl castanospermine (MDL 28,574) in the murine zosteriform model of HSV-1 infection.
    Bridges CG; Ahmed SP; Kang MS; Nash RJ; Porter EA; Tyms AS
    Glycobiology; 1995 Mar; 5(2):249-53. PubMed ID: 7780200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Herpes simplex virus infections.
    Whitley RJ; Roizman B
    Lancet; 2001 May; 357(9267):1513-8. PubMed ID: 11377626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate on genital lesions and encephalitis induced by Herpesvirus hominis type 2 in female mice.
    Allen LB; Hintz OJ; Wolf SM; Huffman JH; Simon LN; Robins RK; Sidwell RW
    J Infect Dis; 1976 Jun; 133 Suppl():A178-83. PubMed ID: 6598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo activity of 1-O-hexadecylpropanediol-3-phospho-ganciclovir and 1-O-hexadecylpropanediol-3-phospho-penciclovir in cytomegalovirus and herpes simplex virus infections.
    Hostetler KY; Rybak RJ; Beadle JR; Gardner MF; Aldern KA; Wright KN; Kern ER
    Antivir Chem Chemother; 2001 Jan; 12(1):61-70. PubMed ID: 11437323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Course and treatment of herpervirus hominis infections. II. Therapy].
    Luger A
    Z Haut Geschlechtskr; 1971 Jul; 46(13):399-408. PubMed ID: 4331019
    [No Abstract]   [Full Text] [Related]  

  • 36. [Herpes simplex infections].
    Kimmig W
    Z Hautkr; 1989 Apr; 64(4):266-8, 271. PubMed ID: 2544060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Resistance of chicks to Herpes simplex virus].
    Cassai E; Menarini L; Corradini L
    Boll Ist Sieroter Milan; 1972; 51(3):173-6. PubMed ID: 4347184
    [No Abstract]   [Full Text] [Related]  

  • 38. Acyclovir topical therapy of cutaneous herpes simplex virus infection in guinea pigs.
    Park NH; Pavan-Langston D; McLean SL; Lass JH
    Arch Dermatol; 1980 Jun; 116(6):672-5. PubMed ID: 7377804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies of the protective effect of gamma globulin against herpes simplex infections in mice.
    CHEEVER FS; DAIKOS G
    J Immunol; 1950 Jul; 65(1):135-41. PubMed ID: 15436993
    [No Abstract]   [Full Text] [Related]  

  • 40. Neonatal herpes simplex virus infections.
    Pinninti SG; Kimberlin DW
    Pediatr Clin North Am; 2013 Apr; 60(2):351-65. PubMed ID: 23481105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.